Jennifer Michaelson's most recent trade in Cullinan Oncology Inc was a trade of 8,000 Common Stock done at an average price of $21.6 . Disclosure was reported to the exchange on Sept. 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.57 per share. | 08 Sep 2026 | 8,000 | 158,844 | - | 21.6 | 172,560 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 08 Sep 2026 | 4,000 | 78,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Sep 2026 | 4,000 | 166,844 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 13 Aug 2026 | 30,000 | 82,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.26 per share. | 13 Aug 2026 | 30,000 | 162,844 | - | 20.3 | 607,800 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 13 Aug 2026 | 30,000 | 192,844 | - | 4.3 | 129,000 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.82 per share. | 06 Jul 2026 | 8,000 | 162,844 | - | 17.8 | 142,560 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jul 2026 | 4,000 | 170,844 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 06 Jul 2026 | 4,000 | 112,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 05 May 2026 | 7,800 | 167,044 | - | 14.6 | 113,880 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 05 May 2026 | 4,000 | 116,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 05 May 2026 | 4,000 | 174,844 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 05 May 2026 | 200 | 166,844 | - | 15.6 | 3,116 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 05 Mar 2026 | 8,000 | 170,844 | - | 15.7 | 125,440 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 05 Mar 2026 | 8,000 | 170,844 | - | 15.7 | 125,440 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 05 Mar 2026 | 8,000 | 170,844 | - | 15.7 | 125,440 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 05 Mar 2026 | 4,000 | 120,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 05 Mar 2026 | 4,000 | 178,844 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 05 Mar 2026 | 4,000 | 178,844 | - | 4.3 | 17,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 05 Mar 2026 | 4,000 | 178,844 | - | 4.3 | 17,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 25 Feb 2026 | 1,780 | 174,844 | - | 14.1 | 25,169 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 25 Feb 2026 | 1,780 | 174,844 | - | 14.1 | 25,169 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 25 Feb 2026 | 1,780 | 174,844 | - | 14.1 | 25,169 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 23 Feb 2026 | 3,601 | 176,624 | - | 14.5 | 52,106 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 23 Feb 2026 | 3,601 | 176,624 | - | 14.5 | 52,106 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 23 Feb 2026 | 3,601 | 176,624 | - | 14.5 | 52,106 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.99 per share. | 23 Feb 2026 | 1,752 | 180,225 | - | 14.0 | 24,510 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.99 per share. | 23 Feb 2026 | 1,752 | 180,225 | - | 14.0 | 24,510 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.99 per share. | 23 Feb 2026 | 1,752 | 180,225 | - | 14.0 | 24,510 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Feb 2026 | 8,000 | 189,977 | - | 4.3 | 34,400 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 20 Feb 2026 | 8,000 | 124,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 20 Feb 2026 | 8,000 | 181,977 | - | 14.3 | 114,400 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Feb 2026 | 8,000 | 189,977 | - | 4.3 | 34,400 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 20 Feb 2026 | 8,000 | 181,977 | - | 14.3 | 114,400 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Feb 2026 | 8,000 | 189,977 | - | 4.3 | 34,400 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.30 per share. | 20 Feb 2026 | 8,000 | 181,977 | - | 14.3 | 114,400 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 20 Feb 2026 | 3,742 | 181,977 | - | 13.6 | 50,966 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 20 Feb 2026 | 3,742 | 181,977 | - | 13.6 | 50,966 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 20 Feb 2026 | 3,742 | 181,977 | - | 13.6 | 50,966 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 18 Feb 2026 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 57,500 | 185,719 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 57,500 | 185,719 | - | 0 | - | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 57,500 | 185,719 | - | 0 | - | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 12 Feb 2026 | 416 | 128,219 | - | 12.0 | 5,004 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 12 Feb 2026 | 416 | 128,219 | - | 12.0 | 5,004 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 12 Feb 2026 | 416 | 128,219 | - | 12.0 | 5,004 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 22 Jan 2026 | 4,000 | 128,635 | - | 12.3 | 49,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 22 Jan 2026 | 4,000 | 128,635 | - | 12.3 | 49,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 22 Jan 2026 | 4,000 | 128,635 | - | 12.3 | 49,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 19 Dec 2025 | 1,345 | 132,635 | - | 10.0 | 13,463 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 19 Dec 2025 | 1,345 | 132,635 | - | 10.0 | 13,463 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 19 Dec 2025 | 1,345 | 132,635 | - | 10.0 | 13,463 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.67 per share. | 18 Dec 2025 | 2,898 | 133,980 | - | 9.7 | 28,024 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.67 per share. | 18 Dec 2025 | 2,898 | 133,980 | - | 9.7 | 28,024 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.67 per share. | 18 Dec 2025 | 2,898 | 133,980 | - | 9.7 | 28,024 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 12 Dec 2025 | 2,148 | 137,873 | - | 12.4 | 26,592 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 12 Dec 2025 | 2,148 | 137,873 | - | 12.4 | 26,592 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 12 Dec 2025 | 2,148 | 137,873 | - | 12.4 | 26,592 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 12 Dec 2025 | 995 | 136,878 | - | 11.9 | 11,841 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 12 Dec 2025 | 995 | 136,878 | - | 11.9 | 11,841 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.90 per share. | 12 Dec 2025 | 995 | 136,878 | - | 11.9 | 11,841 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 24 Nov 2025 | 4,000 | 138,004 | - | 12.3 | 49,200 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 24 Nov 2025 | 4,000 | 138,004 | - | 12.3 | 49,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 24 Nov 2025 | 4,000 | 138,004 | - | 12.3 | 49,200 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 142,004 | - | 8.5 | 32,039 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 142,004 | - | 8.5 | 32,039 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 142,004 | - | 8.5 | 32,039 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 19 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 145,760 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 145,760 | - | 0 | - | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 145,760 | - | 0 | - | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 06 Jan 2025 | 4,000 | 95,760 | - | 12.5 | 50,040 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 06 Jan 2025 | 4,000 | 95,760 | - | 12.5 | 50,040 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 06 Jan 2025 | 4,000 | 95,760 | - | 12.5 | 50,040 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,693 | 99,760 | - | 11.4 | 53,547 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 12 Dec 2024 | 3,489 | 104,453 | - | 12.5 | 43,682 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 05 Nov 2024 | 8,000 | 107,942 | - | 15.6 | 125,120 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 05 Sep 2024 | 8,000 | 115,942 | - | 18.1 | 144,720 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 05 Jul 2024 | 8,000 | 123,942 | - | 16.3 | 130,640 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 9.00 per share. | 01 Jul 2024 | 2,360 | 131,942 | - | 9 | 21,240 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 50,000 | 187,582 | - | 4.3 | 215,000 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 06 May 2024 | 50,000 | 138,593 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 06 May 2024 | 37,723 | 149,859 | - | 27.8 | 1,049,454 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 06 May 2024 | 20,277 | 129,582 | - | 28.5 | 578,706 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 06 May 2024 | 5,606 | 132,987 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 06 May 2024 | 5,606 | 129,582 | - | 30.1 | 168,516 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 5,606 | 135,188 | - | 4.3 | 24,106 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 137,582 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,145 | 87,582 | - | 8.5 | 9,733 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 238 | 88,727 | - | 8.2 | 1,956 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 12 Dec 2023 | 1,068 | 88,965 | - | 7.8 | 8,341 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 238 | 90,033 | - | 12.9 | 3,080 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 12 Jun 2023 | 176 | 90,271 | - | 13.1 | 2,307 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 12 Jun 2023 | 176 | 90,271 | - | 13.1 | 2,307 | - |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 11,900 | 102,347 | - | 4.3 | 51,170 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | 06 Jun 2023 | 11,900 | 188,693 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 06 Jun 2023 | 11,900 | 90,447 | - | 12.3 | 146,489 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | 06 Jun 2023 | 100 | 188,593 | - | - | Stock Option (Right to Buy) | ||
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 06 Jun 2023 | 100 | 90,447 | - | 12.4 | 1,240 | Common Stock |
| Cullinan Oncology Inc | Dr. Jennifer Michaelson, PhD | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 100 | 90,547 | - | 4.3 | 430 | Common Stock |